SCLN

SciClone Pharmaceuticals Appoints Gary Titus as Chief Financial Officer - 12/02 - 06:30 AM ET

SciClone Secures $6 Million in Debt Financing From Silicon Valley Bank - 11/19 - 06:30 AM ET

SciClone Pharmaceuticals Inc and FDA reach agreement for Phase 3 thymalfasin trial in stage IV melanoma - 11/18 - 08:28 AM ET

SCLN: Agreement w/FDA re SPA for Phase 3 Trial of Thymalfasin - 11/17 - 08:44 AM ET

SciClone Reaches Agreement With FDA on Special Protocol Assessment for Phase 3 Thymalfasin Trial in Stage IV Melanoma - 11/17 - 06:30 AM ET

SCLN: To Present At Rodman & Renshaw Investment Conference @ 12:00 ET [delayed] - 11/12 - 10:27 AM ET

SciClone's Phase III hepatitis trial fails endpoint - 11/06 - 09:31 AM ET

SciClone Reports 52% Revenue Growth and a Profit in the Third Quarter of 2008 - 11/06 - 06:30 AM ET

UPDATE 2-SciClone's hepatitis C drug fails main goal - 11/05 - 04:29 PM ET

SciClone and Sigma-Tau Report Phase 3 Hepatitis C Trial Results - 11/05 - 06:40 AM ET

SciClone Pharmaceuticals to Present at Rodman & Renshaw Global Investment Conference - 11/05 - 06:30 AM ET

SciClone Pharmaceuticals to Report Third Quarter 2008 Results on November 6, 2008 - 10/27 - 06:30 AM ET

SCLN: To Present At UBS Global Life Sciences Conference @ 13:00 ET [delayed] - 09/25 - 11:23 AM ET

SciClone reports encouraging results from Phase IIa hepatitis trial - 09/23 - 07:00 AM ET

SCLN: Positive Data from Phase 2 Trial of SCV-07 in Chronic Hepatitis C - 09/22 - 08:12 AM ET

SciClone Provides Promising Results From Its Phase 2A Clinical Trial Using SCV-07 as a Monotherapy in Patients With Chronic Hepatitis C Infection - 09/22 - 06:30 AM ET

SciClone Pharmaceuticals Appoints Jeffery Lange as Vice President, Business Development - 08/07 - 06:30 AM ET

SCLN: Q2 Earnings Call @ 11:00 ET Today [delayed] - 07/29 - 08:24 AM ET

SciClone Pharmaceuticals to Report Second Quarter 2008 Results on July 29, 2008 - 07/25 - 06:30 AM ET

SciClone Pharmaceuticals (SCLN) Corporate Event Announcement Notice - 07/11 - 09:09 PM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index